Developer docs
API playgroundTry for free, no card

Search company profiles

Sparkling Sciences

Full company profile

uuid00kd9o8

Namestring
Sparkling Sciences
Legal namestring
氣泡科技股份有限公司
Company typeenum
Private
Founded yearint
2024
Descriptiontext

Sparkling Sciences Co., Ltd. (氣泡科技股份有限公司) is a Taiwan-based biotechnology company founded in 2024 as the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). The company specializes in exosome and extracellular vesicle (EV) technology, offering high-purity extraction and mass production of exosomes derived from multiple animal cell sources — Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) — as well as from plant cells. Its core technical platform combines proprietary lyophilization (freeze-drying) technology operating at -40°C to -80°C, which preserves exosome bioactivity without thermal degradation and enables room-temperature shelf stability, reducing cold-chain dependency for global distribution.

The company operates a B2B ingredients-and-services model targeting cosmetics and skincare brands, pet health companies, and research institutions. Revenue is generated through (1) supply of exosome and plant EV raw materials in lyophilized powder and frozen liquid formats, (2) OEM/ODM contract manufacturing for cosmetics and skincare brands, and (3) fee-for-service lyophilization processing for third-party exosomes, proteins, and natural extracts. Two ingredients have obtained INCI (International Nomenclature of Cosmetic Ingredients) registration — Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956) — with an iPSC Exosome INCI registration announced in mid-2026. The company has also launched four consumer-facing sub-brands (Karela, MUiKA, J-STARMi, iLISSE) and established a Tokyo subsidiary, ArcBio Co., Ltd., in 2025 to support Japan market entry.

Short descriptiontext

Sparkling Sciences is a Taiwan-based biotechnology company founded in 2024 that extracts, mass-produces, and lyophilizes exosomes from animal and plant cells, supplying INCI-registered raw materials, OEM/ODM services, and consumer sub-brands to cosmetics, skincare, and pet health clients across Asia-Pacific.

Operating statusenum
Operating
Ownership categoryenum
akta.pro rankint
HeadquartersTaichung City, Taiwan
HQ citystring
Taichung City
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
exosome raw materials, plant extracellular vesicles, cosmetic OEM manufacturing, lyophilization services, pet biotech ingredients
Industry1 code
PRIMARYHLAGABAI
Lyophilization (Freeze-Drying) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Biotechnology Ingredients and OEM Manufacturing
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Exosome and Cell Raw Materials Supply
TypeOne Time License
Description

Supply of high-purity exosome raw materials (animal and plant-derived) to cosmetics and skincare brands, pet health companies, and research institutions. Offered in lyophilized powder (long-term stable) and frozen liquid (high activity) formats, with customization options for cell source, concentration, and packaging.

sparklingsci.com
2OEM/ODM Contract Manufacturing
TypeProfessional Services
Description

One-stop OEM/ODM services for cosmetics and skincare brands, from concept design to finished product manufacturing, leveraging exosome-based and plant EV-based ingredient formulations. Supports brand partners in developing differentiated skincare, haircare, and pet wellness products.

sparklingsci.com
3Lyophilization (Freeze-Drying) Service
TypeTransaction Fee
Description

Fee-for-service lyophilization processing for third-party exosomes, proteins, natural plant extracts, and cytokines, serving research institutions, biotech companies, and cosmetics manufacturers needing preserved bioactive samples.

sparklingsci.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components2 values
Personnel, Technology or R&D
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 4 records shown
1Karela
Description

Plant-derived skincare brand featuring natural ingredients for skin health.

en.sparklingsci.com
+3 more records
Core offering1 text field

Sparkling Sciences is a Taiwan-based biotechnology company that extracts, mass-produces, and supplies exosome and plant extracellular vesicle (EV) raw materials derived from animal cells (MSC, iPSC, Fibroblast, NSC, HPC) and functional plant sources. The company sells INCI-registered cosmetic ingredients, provides pet exosome customization, and offers end-to-end OEM/ODM contract manufacturing for skincare and haircare brands, supported by proprietary lyophilization (freeze-drying) technology for shelf-stable bioactive products.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Exosome freeze-drying technology enables room-temperature shelf stability, reducing cold-chain dependency and transport risk for global distribution
+1 more record
Product overview1 text field

Sparkling Sciences (氣泡科技股份有限公司) operates as a biotechnology company specializing in exosome technology research, development, and manufacturing. The company offers a comprehensive portfolio comprising: (1) Stem cell products including Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) for pet applications; (2) Exosome extraction and mass production services for both animal-derived and plant-derived extracellular vesicles; (3) Professional lyophilization (freeze-drying) services for preserving bioactive molecules; (4) Cosmetic/skincare raw materials and OEM/ODM contract manufacturing services; and (5) INCI-certified exosome ingredients including Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956). The company also develops consumer-facing brands including Karela (plant skincare), MUiKA (hair growth), J-STARMi (high-concentration exosome serum), and iLISSE (sensitive skin). Core technology focuses on freeze-drying preservation and high-purity exosome extraction for applications in beauty, health, and pet care sectors.

Product and service15 records
1Human Hair Follicle Dermal Papilla Cell Exosomes (人類毛囊真皮乳突細胞外泌體)
CategoryRaw Material / Ingredient
Description

Exosome raw material derived from human hair follicle dermal papilla cells (HFDPCs) through rigorous culture, purification, and standardized quality manufacturing. INCI certified (INCI ID: 40983) for cosmetic ingredient labeling and scalp/skin product development. Sold to cosmetics brands as a B2B raw material.

2Organic Rice Bran-Derived Vesicles (米糠胞外體)
CategoryRaw Material / Ingredient
Description

Extracellular vesicles extracted from organic rice bran using standardized separation and nano-level EV technology. INCI certified (INCI ID: 40956) for cosmetic formulations targeting hair volumizing, moisturizing, and skin refining. Sold as a B2B raw material to skincare and haircare brands.

3Mesenchymal Stem Cells (MSC) - Pet Cell Product
CategoryCell Product / Service
Description

Mesenchymal stem cells derived from cats and dogs bone marrow, adipose tissue, and umbilical cords. Exhibits high proliferative capacity and multipotent differentiation potential for gene preservation and pet health management applications. Sold as a customized B2B cell product.

4Induced Pluripotent Stem Cells (iPSC) - Pet Cell Product
CategoryCell Product / Service
Description

Cells reprogrammed from cats and dogs back to a pluripotent state for gene preservation and biomedical research. Sold as a customized B2B cell product for veterinary and biomedical applications.

5Fibroblast - Pet Cell Product
CategoryCell Product / Service
Description

Fibroblast-derived exosomes from cats and dogs, rich in collagen-related factors for skin conditioning and pet health applications. Sold as a customized B2B cell product.

6Neural Stem Cells (NSC) - Pet Cell Product
CategoryCell Product / Service
Description

Neural stem cell-derived exosomes with nerve factors for studies of neuronal function and central nervous system health in cats and dogs. Sold as a customized B2B cell product.

7Hair Precursor Cells (HPC) - Pet Cell Product
CategoryCell Product / Service
Description

Hair precursor cell exosomes rich in nutritional factors relevant to hair follicle vitality, supporting hair quality and density research in cats and dogs. Sold as a customized B2B cell product.

8Pet Exosome Extraction and Mass Production (寵物外泌體萃取量產)
CategoryService
Description

Customized exosome extraction and mass production service from MSC, iPSC, Fibroblast, NSC, HPC, and plant cell sources, available in lyophilized powder (long-term storage) and frozen liquid (high activity) formats. Sold as a B2B service to pet health and veterinary companies.

9Plant Extracellular Vesicles Extraction and Mass Production (植物胞外囊泡萃取量產)
CategoryService
Description

High-purity extraction and scalable production of plant-derived extracellular vesicles from functional plant sources, suitable for nutraceuticals, skincare, and haircare products. Available in lyophilized powder and frozen liquid formats with customization options. Sold as a B2B service.

10Exosome Lyophilization Service (外泌體冷凍乾燥服務)
CategoryService
Description

Professional fee-for-service lyophilization (freeze-drying) using low-temperature vacuum sublimation (-40°C to -80°C) to preserve exosomes, proteins, natural plant extracts, and cytokines for third-party biotech companies, research institutions, and cosmetics manufacturers. Reduces cold-chain dependency for global distribution.

11Cosmetics/Skincare Raw Materials and OEM/ODM (化妝/保養品原物料及OEM/ODM)
CategoryService
Description

One-stop OEM/ODM contract manufacturing service combining supply of high-quality, stable exosome raw materials with end-to-end brand product manufacturing from concept design to finished product. Offers customization for repair, anti-aging, brightening, and moisturizing skincare applications.

12Karela - Plant-Derived Skincare Brand
CategoryBrand / Consumer Product
Description

Plant-derived skincare brand featuring natural ingredients developed using Sparkling Sciences' exosome technology for skin health applications. Showcased to B2B partners at trade exhibitions.

13MUiKA - Hair Growth Brand
CategoryBrand / Consumer Product
Description

Hair growth brand utilizing high-activity freeze-dried exosome technology for scalp and hair care applications. Showcased to B2B partners at trade exhibitions.

14J-STARMi - High-Concentration Exosome Serum
CategoryBrand / Consumer Product
Description

High-concentration exosome serum featuring proprietary freeze-drying technology to preserve exosome activity, positioned as a premium skincare product. Showcased to B2B partners at trade exhibitions.

15iLISSE - Sensitive Skin Brand
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Tomo Yume Bio-Tech (友夢生醫)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Sparkling Sciences is the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). Tomo Yume Bio-Tech is the parent company and holding entity, with Sparkling Sciences serving as the dedicated R&D and manufacturing arm for exosome ingredients. Dr. Jen Kao founded Tomo Yume Bio-Tech in 2024 and established Sparkling Sciences as its R&D subsidiary in the same year. The two entities exhibit together at industry events, such as the 2026 Taipei Pet Products Expo, presenting combined pet biotechnology innovations.

sparklingsci.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

South Korean biotechnology company specializing in exosome-based cosmetic ingredients and stem cell-derived skincare products. Direct competitor targeting the same B2B cosmetics ingredient market with similar INCI-registered exosome offerings.

TypeEmerging player
Description

Portuguese biotechnology company developing exosome-based products for regenerative medicine and cosmetics. Emerging peer with partial overlap in exosome manufacturing and skin/hair applications.

3Amorepacific Corporation
TypeBroad incumbent
Description

Major South Korean cosmetics conglomerate with significant in-house biotechnology research including exosome and stem cell programs for skincare. Represents a larger incumbent that competes for the same B2B brand and consumer markets with broader product portfolios.

TypeDirect peer
Description

US biotechnology company specializing in exosome isolation and production for regenerative medicine and skincare applications. Direct competitor with similar exosome manufacturing capabilities targeting cosmetics and therapeutic markets.

TypeRegional player
Description

Asian biotech developing cell-based and exosome technologies for skincare and pharmaceutical applications. Regional peer operating in adjacent Asia-Pacific markets with comparable bioactive ingredient offerings.

6Codi Biobiosciences
TypeEmerging player
Description

Korean biotech firm developing extracellular vesicle and exosome-based ingredients for cosmetic and therapeutic applications. Emerging peer with similar cell-sourced exosome technology targeting skincare brands.

TypeDirect peer
Description

US-based company producing exosome-based regenerative skincare products and cosmetic ingredients for professional use. Direct competitor offering similar lyophilized exosome raw materials and OEM-style services to skincare brands.

TypeDirect peer
Description

US company offering exosome-based regenerative skincare products and professional treatment systems. Comparable as a peer developing exosome-based cosmetic products for both consumer and professional B2B channels.

9ExoPro Medical
TypeEmerging player
Description

Biotech company developing exosome-based products for skin regeneration and cosmetic applications. Emerging peer with overlapping R&D focus on plant and animal-derived exosome ingredients for skincare.

10Shiseido Company
TypeBroad incumbent
Description

Major Japanese cosmetics company with extensive biotech research including exosome and regenerative skincare programs. Direct presence in Sparkling Sciences' home market of Japan and Taiwan, competing for premium skincare brand partnerships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Sparkling Sciences

Biotechnology Ingredients and OEM Manufacturingsparklingsci.com

Sparkling Sciences is a Taiwan-based biotechnology company founded in 2024 that extracts, mass-produces, and lyophilizes exosomes from animal and plant cells, supplying INCI-registered raw materials, OEM/ODM services, and consumer sub-brands to cosmetics, skincare, and pet health clients across Asia-Pacific.

What Sparkling Sciences does

Sparkling Sciences Co., Ltd. (氣泡科技股份有限公司) is a Taiwan-based biotechnology company founded in 2024 as the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). The company specializes in exosome and extracellular vesicle (EV) technology, offering high-purity extraction and mass production of exosomes derived from multiple animal cell sources — Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) — as well as from plant cells. Its core technical platform combines proprietary lyophilization (freeze-drying) technology operating at -40°C to -80°C, which preserves exosome bioactivity without thermal degradation and enables room-temperature shelf stability, reducing cold-chain dependency for global distribution.

The company operates a B2B ingredients-and-services model targeting cosmetics and skincare brands, pet health companies, and research institutions. Revenue is generated through (1) supply of exosome and plant EV raw materials in lyophilized powder and frozen liquid formats, (2) OEM/ODM contract manufacturing for cosmetics and skincare brands, and (3) fee-for-service lyophilization processing for third-party exosomes, proteins, and natural extracts. Two ingredients have obtained INCI (International Nomenclature of Cosmetic Ingredients) registration — Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956) — with an iPSC Exosome INCI registration announced in mid-2026. The company has also launched four consumer-facing sub-brands (Karela, MUiKA, J-STARMi, iLISSE) and established a Tokyo subsidiary, ArcBio Co., Ltd., in 2025 to support Japan market entry.

Sparkling Sciences firmographics

Firmographics
Name
Sparkling Sciences
Legal name
氣泡科技股份有限公司
Website
https://sparklingsci.com
Company type
Private
Founded year
2024
Operating status
Operating
Short description
Sparkling Sciences is a Taiwan-based biotechnology company founded in 2024 that extracts, mass-produces, and lyophilizes exosomes from animal and plant cells, supplying INCI-registered raw materials, OEM/ODM services, and consumer sub-brands to cosmetics, skincare, and pet health clients across Asia-Pacific.
Ownership category
akta.pro rank

Sparkling Sciences industry classification

Industry
Product category
Biotechnology Ingredients and OEM Manufacturing
NAICS
Medicinal and Botanical Manufacturing (325411)
SIC
Medicinal Chemicals & Botanical Products (2833)
akta.pro industry
PRIMARYHLAGABAI
Lyophilization (Freeze-Drying) CDMO
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Development & Manufacturing Organizations (CDMO)

Keywords

  • Exosome raw materials
  • Plant extracellular vesicles
  • Cosmetic OEM manufacturing
  • Lyophilization services
  • Pet biotech ingredients

Where Sparkling Sciences is headquartered

Location

Headquarters

HQ city
Taichung City
HQ country
Taiwan
HQ region
Asia

Offices3 records

Markets served

Sparkling Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D

Revenue model

  1. Exosome and Cell Raw Materials Supply: Supply of high-purity exosome raw materials (animal and plant-derived) to cosmetics and skincare brands, pet health companies, and research institutions. Offered in lyophilized powder (long-term stable) and frozen liquid (high activity) formats, with customization options for cell source, concentration, and packaging.
  2. OEM/ODM Contract Manufacturing: One-stop OEM/ODM services for cosmetics and skincare brands, from concept design to finished product manufacturing, leveraging exosome-based and plant EV-based ingredient formulations. Supports brand partners in developing differentiated skincare, haircare, and pet wellness products.
  3. Lyophilization (Freeze-Drying) Service: Fee-for-service lyophilization processing for third-party exosomes, proteins, natural plant extracts, and cytokines, serving research institutions, biotech companies, and cosmetics manufacturers needing preserved bioactive samples.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Sparkling Sciences product offering

Product offering

Core offering

Sparkling Sciences is a Taiwan-based biotechnology company that extracts, mass-produces, and supplies exosome and plant extracellular vesicle (EV) raw materials derived from animal cells (MSC, iPSC, Fibroblast, NSC, HPC) and functional plant sources. The company sells INCI-registered cosmetic ingredients, provides pet exosome customization, and offers end-to-end OEM/ODM contract manufacturing for skincare and haircare brands, supported by proprietary lyophilization (freeze-drying) technology for shelf-stable bioactive products.

Product overview

Sparkling Sciences (氣泡科技股份有限公司) operates as a biotechnology company specializing in exosome technology research, development, and manufacturing. The company offers a comprehensive portfolio comprising: (1) Stem cell products including Mesenchymal Stem Cells (MSC), Induced Pluripotent Stem Cells (iPSC), Fibroblasts, Neural Stem Cells (NSC), and Hair Precursor Cells (HPC) for pet applications; (2) Exosome extraction and mass production services for both animal-derived and plant-derived extracellular vesicles; (3) Professional lyophilization (freeze-drying) services for preserving bioactive molecules; (4) Cosmetic/skincare raw materials and OEM/ODM contract manufacturing services; and (5) INCI-certified exosome ingredients including Human Hair Follicle Dermal Papilla Cell Exosomes (INCI ID: 40983) and Organic Rice Bran-Derived Vesicles (INCI ID: 40956). The company also develops consumer-facing brands including Karela (plant skincare), MUiKA (hair growth), J-STARMi (high-concentration exosome serum), and iLISSE (sensitive skin). Core technology focuses on freeze-drying preservation and high-purity exosome extraction for applications in beauty, health, and pet care sectors.

Differentiator

Problem solved

Functional benefit

Brands

  • Karela: Plant-derived skincare brand featuring natural ingredients for skin health.
  • MUiKA
  • J-STARMi
  • iLISSE

Products and services

  • Human Hair Follicle Dermal Papilla Cell Exosomes (人類毛囊真皮乳突細胞外泌體) Exosome raw material derived from human hair follicle dermal papilla cells (HFDPCs) through rigorous culture, purification, and standardized quality manufacturing. INCI certified (INCI ID: 40983) for cosmetic ingredient labeling and scalp/skin product development. Sold to cosmetics brands as a B2B raw material.
  • Organic Rice Bran-Derived Vesicles (米糠胞外體) Extracellular vesicles extracted from organic rice bran using standardized separation and nano-level EV technology. INCI certified (INCI ID: 40956) for cosmetic formulations targeting hair volumizing, moisturizing, and skin refining. Sold as a B2B raw material to skincare and haircare brands.
  • Mesenchymal Stem Cells (MSC) - Pet Cell Product Mesenchymal stem cells derived from cats and dogs bone marrow, adipose tissue, and umbilical cords. Exhibits high proliferative capacity and multipotent differentiation potential for gene preservation and pet health management applications. Sold as a customized B2B cell product.
  • Induced Pluripotent Stem Cells (iPSC) - Pet Cell Product Cells reprogrammed from cats and dogs back to a pluripotent state for gene preservation and biomedical research. Sold as a customized B2B cell product for veterinary and biomedical applications.
  • Fibroblast - Pet Cell Product Fibroblast-derived exosomes from cats and dogs, rich in collagen-related factors for skin conditioning and pet health applications. Sold as a customized B2B cell product.
  • Neural Stem Cells (NSC) - Pet Cell Product Neural stem cell-derived exosomes with nerve factors for studies of neuronal function and central nervous system health in cats and dogs. Sold as a customized B2B cell product.
  • Hair Precursor Cells (HPC) - Pet Cell Product Hair precursor cell exosomes rich in nutritional factors relevant to hair follicle vitality, supporting hair quality and density research in cats and dogs. Sold as a customized B2B cell product.
  • Pet Exosome Extraction and Mass Production (寵物外泌體萃取量產) Customized exosome extraction and mass production service from MSC, iPSC, Fibroblast, NSC, HPC, and plant cell sources, available in lyophilized powder (long-term storage) and frozen liquid (high activity) formats. Sold as a B2B service to pet health and veterinary companies.
  • Plant Extracellular Vesicles Extraction and Mass Production (植物胞外囊泡萃取量產) High-purity extraction and scalable production of plant-derived extracellular vesicles from functional plant sources, suitable for nutraceuticals, skincare, and haircare products. Available in lyophilized powder and frozen liquid formats with customization options. Sold as a B2B service.
  • Exosome Lyophilization Service (外泌體冷凍乾燥服務) Professional fee-for-service lyophilization (freeze-drying) using low-temperature vacuum sublimation (-40°C to -80°C) to preserve exosomes, proteins, natural plant extracts, and cytokines for third-party biotech companies, research institutions, and cosmetics manufacturers. Reduces cold-chain dependency for global distribution.
  • Cosmetics/Skincare Raw Materials and OEM/ODM (化妝/保養品原物料及OEM/ODM) One-stop OEM/ODM contract manufacturing service combining supply of high-quality, stable exosome raw materials with end-to-end brand product manufacturing from concept design to finished product. Offers customization for repair, anti-aging, brightening, and moisturizing skincare applications.
  • Karela - Plant-Derived Skincare Brand Plant-derived skincare brand featuring natural ingredients developed using Sparkling Sciences' exosome technology for skin health applications. Showcased to B2B partners at trade exhibitions.
  • MUiKA - Hair Growth Brand Hair growth brand utilizing high-activity freeze-dried exosome technology for scalp and hair care applications. Showcased to B2B partners at trade exhibitions.
  • J-STARMi - High-Concentration Exosome Serum High-concentration exosome serum featuring proprietary freeze-drying technology to preserve exosome activity, positioned as a premium skincare product. Showcased to B2B partners at trade exhibitions.
  • iLISSE - Sensitive Skin Brand

Quantifiable outcome

  • Exosome freeze-drying technology enables room-temperature shelf stability, reducing cold-chain dependency and transport risk for global distribution
  • +1 more outcomes

Companies that use Sparkling Sciences

Customer profile

Segments3 records

Ideal customer profiles3 records

Sparkling Sciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Sparkling Sciences partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Tomo Yume Bio-Tech (友夢生醫)coreStrategic or Co-development Partner · 1 September 2025Sparkling Sciences is the R&D subsidiary of Tomo Yume Bio-Tech (友夢生醫). Tomo Yume Bio-Tech is the parent company and holding entity, with Sparkling Sciences serving as the dedicated R&D and manufacturing arm for exosome ingredients. Dr. Jen Kao founded Tomo Yume Bio-Tech in 2024 and established Sparkling Sciences as its R&D subsidiary in the same year. The two entities exhibit together at industry events, such as the 2026 Taipei Pet Products Expo, presenting combined pet biotechnology innovations.

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Sparkling Sciences competitors and assessment

Company assessment

Direct peers

  • ExoCoBio: South Korean biotechnology company specializing in exosome-based cosmetic ingredients and stem cell-derived skincare products. Direct competitor targeting the same B2B cosmetics ingredient market with similar INCI-registered exosome offerings.
  • Kimera Labs: US biotechnology company specializing in exosome isolation and production for regenerative medicine and skincare applications. Direct competitor with similar exosome manufacturing capabilities targeting cosmetics and therapeutic markets.
  • BENEV Company Inc. US-based company producing exosome-based regenerative skincare products and cosmetic ingredients for professional use. Direct competitor offering similar lyophilized exosome raw materials and OEM-style services to skincare brands.
  • Rion Aesthetics: US company offering exosome-based regenerative skincare products and professional treatment systems. Comparable as a peer developing exosome-based cosmetic products for both consumer and professional B2B channels.

Emerging players

  • Stemmatters: Portuguese biotechnology company developing exosome-based products for regenerative medicine and cosmetics. Emerging peer with partial overlap in exosome manufacturing and skin/hair applications.
  • Codi Biobiosciences: Korean biotech firm developing extracellular vesicle and exosome-based ingredients for cosmetic and therapeutic applications. Emerging peer with similar cell-sourced exosome technology targeting skincare brands.
  • ExoPro Medical: Biotech company developing exosome-based products for skin regeneration and cosmetic applications. Emerging peer with overlapping R&D focus on plant and animal-derived exosome ingredients for skincare.

Broad incumbents

  • Amorepacific Corporation: Major South Korean cosmetics conglomerate with significant in-house biotechnology research including exosome and stem cell programs for skincare. Represents a larger incumbent that competes for the same B2B brand and consumer markets with broader product portfolios.
  • Shiseido Company: Major Japanese cosmetics company with extensive biotech research including exosome and regenerative skincare programs. Direct presence in Sparkling Sciences' home market of Japan and Taiwan, competing for premium skincare brand partnerships.

Regional players

  • Cellavision: Asian biotech developing cell-based and exosome technologies for skincare and pharmaceutical applications. Regional peer operating in adjacent Asia-Pacific markets with comparable bioactive ingredient offerings.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Sparkling Sciences compliance and trust

Trust signal

Compliance2 records

Sparkling Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Sparkling Sciences leadership team

Management profile

Number of profiles

Profiles1 record

Sparkling Sciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Sparkling Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Sparkling Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sparkling Sciences

What does Sparkling Sciences do?

Sparkling Sciences is a Taiwan-based biotechnology company that extracts, mass-produces, and supplies exosome and plant extracellular vesicle (EV) raw materials derived from animal cells (MSC, iPSC, Fibroblast, NSC, HPC) and functional plant sources. The company sells INCI-registered cosmetic ingredients, provides pet exosome customization, and offers end-to-end OEM/ODM contract manufacturing for skincare and haircare brands, supported by proprietary lyophilization (freeze-drying) technology for shelf-stable bioactive products.

Is Sparkling Sciences a public or private company?

Sparkling Sciences is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Sparkling Sciences founded?

Sparkling Sciences was founded in 2024.

Where is Sparkling Sciences based?

Sparkling Sciences is headquartered in Taichung City, Taiwan, in the Asia region.

How does Sparkling Sciences make money?

Three revenue lines are on record. Exosome and Cell Raw Materials Supply is the primary driver. The others are OEM/ODM Contract Manufacturing and lyophilization (Freeze-Drying) Service.

Who are Sparkling Sciences's main competitors?

Direct peers on record are ExoCoBio, Kimera Labs, BENEV Company Inc. and Rion Aesthetics. Emerging players are Stemmatters, Codi Biobiosciences and ExoPro Medical. Broad incumbents are Amorepacific Corporation and Shiseido Company. Cellavision is listed as a regional player.

Does Sparkling Sciences have an API?

No public API is recorded for Sparkling Sciences.

What industry is Sparkling Sciences in?

Sparkling Sciences's product category is Biotechnology Ingredients and OEM Manufacturing. Its primary akta.pro industry code is HLAGABAI, Lyophilization (Freeze-Drying) CDMO. Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals